Clinical Trials Show Relapsing Multiple Sclerosis Patients Benefit from MAVENCLAD, A New Drug by MERCK
Merck Sdn Bhd has launched MAVENCLAD (cladribine), a short-course oral therapy now approved in Malaysia for the treatment of adult...
Merck Sdn Bhd has launched MAVENCLAD (cladribine), a short-course oral therapy now approved in Malaysia for the treatment of adult...